Acute Myeloid Leukemia Following Myelodysplastic Syndrome and Failure of Therapy with Hypomethylating Agents: An Emerging Entity With a Poor Prognosis

We assessed outcome of 63 patients with acute myeloid leukemia (AML) arising from myelodysplastic syndrome (MDS) failing hypomethylating agents (HMA). Median age was 63 years. All 63 patients received at least 1 salvage regimen for AML and 35 patients (55%) received 2 or more. Of the 31 patients (49...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Jabbour, Elias, Ghanem, Hady, Huang, Xuelin, Ravandi, Farhad, Garcia-Manero, Guillermo, O’Brien, Susan, Faderl, Stephan, Pierce, Sherry, Choi, Sangbum, Verstovsek, Srdan, Brandt, Mark, Cortes, Jorge, Kantarjian, Hagop
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4098769/
https://ncbi.nlm.nih.gov/pubmed/24447728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2013.10.013
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller